# Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix

> **NCT04011059** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hospital San Vicente Fundación** · enrollment: 40 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Heart Failure
- Coronary Artery Disease
- Mesenchymal Stem Cell Transplantation
- Regenerative Medicine

## Interventions

- **BIOLOGICAL:** Wharton's jelly-derived mesenchymal cells

## Key facts

- **NCT ID:** NCT04011059
- **Lead sponsor:** Hospital San Vicente Fundación
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-02
- **Primary completion:** 2022-01-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-07-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011059, "Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04011059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*